{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:31:48Z","timestamp":1754195508436},"reference-count":26,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007313","name":"MD Anderson Cancer Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MD Anderson Cancer Center Support","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}]}],"content-domain":{"domain":["lrjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.leukres.2014.08.007","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T16:33:13Z","timestamp":1409243593000},"page":"1212-1216","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical significance of microcytosis in patients with primary myelofibrosis"],"prefix":"10.1016","volume":"38","author":[{"given":"Paolo","family":"Strati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Pemmaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeev","family":"Estrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marylou","family":"Cardenas-Turanzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate J.","family":"Newberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naval","family":"Daver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2014.08.007_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mayocp.2011.11.001","article-title":"One thousand patients with primary myelofibrosis: the mayo clinic experience","volume":"87","author":"Tefferi","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.leukres.2014.08.007_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.med.60.041707.160528","article-title":"Primary myelofibrosis: update on definition, pathogenesis, and treatment","volume":"60","author":"Abdel-Wahab","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.leukres.2014.08.007_bib0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.leukres.2005.10.006","article-title":"Microcytosis in agnogenic myeloid metaplasia: prevalence and clinical correlates","volume":"30","author":"Tefferi","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2014.08.007_bib0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11739-010-0387-4","article-title":"Recent advances in iron metabolism and related disorders","volume":"5","author":"Camaschella","year":"2010","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.leukres.2014.08.007_bib0025","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1182\/blood-2013-06-508325","article-title":"A systematic analysis of global anemia burden from 1990 to 2010","volume":"123","author":"Kassebaum","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.08.007_bib0030","first-page":"89","article-title":"Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes","volume":"7","author":"Mughal","year":"2014","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.leukres.2014.08.007_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ajh.23406","article-title":"Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis","volume":"88","author":"Pardanani","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2014.08.007_bib0040","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.leukres.2014.08.007_bib0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2014.08.007_bib0050","series-title":"Thalassemia. Hematology\/the Education Program of the American Society of Hematology American Society of Hematology Education Program","first-page":"14","author":"Cohen","year":"2004"},{"key":"10.1016\/j.leukres.2014.08.007_bib0055","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1182\/blood-2004-07-2792","article-title":"Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies","volume":"105","author":"Steensma","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.08.007_bib0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-8981(81)90354-5","article-title":"Balanced globin synthesis in idiopathic myelofibrosis","volume":"110","author":"Ballas","year":"1981","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"10.1016\/j.leukres.2014.08.007_bib0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajh.2830060304","article-title":"Acquired hemoglobin H disease in idiopathic myelofibrosis","volume":"6","author":"Veer","year":"1979","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2014.08.007_bib0070","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.08.007_bib0075","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2014.08.007_bib0080","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","article-title":"DIPSS plus: a refined dynamic international prognostic scoring system for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status","volume":"29","author":"Gangat","year":"2011","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.leukres.2014.08.007_bib0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/leu.2010.234","article-title":"Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients","volume":"25","author":"Caramazza","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2014.08.007_bib0090","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ejh.12150","article-title":"Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia","volume":"91","author":"Tarkun","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2014.08.007_bib0095","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3324\/haematol.2012.075515","article-title":"Iron refractory iron deficiency anemia","volume":"98","author":"De Falco","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2014.08.007_bib0100","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1100\/tsw.2011.130","article-title":"Molecular mechanisms regulating hepcidin revealed by hepcidin disorders","volume":"11","author":"Camaschella","year":"2011","journal-title":"Sci World J"},{"key":"10.1016\/j.leukres.2014.08.007_bib0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cell.2010.06.028","article-title":"Two to tango: regulation of mammalian iron metabolism","volume":"142","author":"Hentze","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2014.08.007_bib0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1600-0609.1982.tb00611.x","article-title":"Assessment of bone marrow and splenic erythropoiesis in myelofibrosis","volume":"29","author":"Ferrant","year":"1982","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.leukres.2014.08.007_bib0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10534-012-9602-2","article-title":"Mossbauer spectroscopy of the iron cores in human liver ferritin, ferritin in normal human spleen and ferritin in spleen from patient with primary myelofibrosis: preliminary results of comparative analysis","volume":"26","author":"Oshtrakh","year":"2013","journal-title":"Biometals: Int J Role Metal Ions Biol Biochem Med"},{"key":"10.1016\/j.leukres.2014.08.007_bib0120","doi-asserted-by":"crossref","first-page":"e75568","DOI":"10.1371\/journal.pone.0075568","article-title":"A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease","volume":"8","author":"Fujiwara","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.leukres.2014.08.007_bib0125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.leukres.2013.04.017","article-title":"Progressive burden of myelofibrosis in untreated patients: assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study","volume":"37","author":"Mesa","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2014.08.007_bib0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2362.2011.02608.x","article-title":"Hepcidin expression in patients with acute leukaemia","volume":"42","author":"Cheng","year":"2012","journal-title":"Eur J Clin Investig"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614002409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212614002409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T02:51:21Z","timestamp":1538275881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212614002409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0145212614002409"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2014.08.007","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical significance of microcytosis in patients with primary myelofibrosis","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2014.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}